Surge in Online Searches and Policy Changes Highlight Growing GLP-1 Weight-Loss Drug Concerns

The recent spike in online interest for GLP-1 medications like Ozempic and Wegovy, fueled by Super Bowl ads, coincides with increased safety risks from unregulated online sales. Meanwhile, US states are limiting Medicaid coverage amid rising demand, raising accessibility issues. The evolving landscape underscores the need for regulated prescribing and consumer caution as demand for these drugs grows.